Navigation Links
Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
Date:10/29/2010

part of our Base Medical Products Segment for purposes of the projections below.  All figures are illustrated in millions of U.S. dollars. REVENUE
2010E
2011E
2012E
2013E   Base Segment
$17
$173
$182
$191   Proprietary Segment
$5
$87
$13
$162 TOTAL

$221
$260
$313
$353ADJUSTED CASH EBITDA
2010E
2011E
2012E
2013E   Base Segment
$42
$45
$49
$52   Proprietary Segment
($38)
($35)
($28)
$6 TOTAL

$4
$10
$21
$58 Angiotech has derived, based primarily on publicly available analyst and industry reports, the following financial projections for its Royalty Segment.  All figures are illustrated in millions of U.S. dollars. ROYALTY SEGMENT
2010E
2011E
2012E
2013E   Total Revenue
$32
$35
$4
$56   Total Adjusted Cash EBITDA
$2
$29
$38
$46

Angiotech has developed the following consolidated financial projections.  Net cash flow prior to financing as illustrated below excludes the effect of any future financing transaction that may provide additional liquidity and capital resources to the Company for investment in working capital and its various business initiatives.  Furthermore, net cash flow prior to financing includes estimates for certain monthly restructuring-related professional fees in 2010E but excludes all restructuring-related charges, fees and expenses thereafter.  These expenses are expected to be significant and will vary depending on the time or process required to complete the proposed recapitalization transaction.  All figures are illustrated in millions of U.S. dollars. CONSOLIDATED
2010E
2011E

'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
2. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
3. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
4. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
5. Angiotech Pharmaceuticals announces time change of conference call and webcast
6. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
7. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
8. Angiotech announces positive results from Bio-Seal(TM) clinical study
9. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
10. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
11. Angiotech announces date of annual general meeting of shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BioLight Life Sciences Investments ... a firm that invests in, manages and commercializes ... today that presentations highlighting its IOPtiMate™ system for ... the Ophthalmology Futures European Forum and the XXXIII ... Refractive Surgeons ("ESCRS"), both taking place in the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Whitehouse Laboratories is excited ... Pharma Ed Resources upcoming educational seminar and training session on Extractable & Leachable ... conference will provide Updates & Case Studies on the Latest Compliance Implications of ...
(Date:9/1/2015)... September 2, 2015 ... die Forschung und Entwicklung neuartiger Therapien für ... Darmerkrankungen und Reizdarm konzentriert, erhält vom US ... sein neues Medikament patentiert wird. Das Medikament ... bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... 1, 2015 Prostate cancer is ... American men. One in seven men will be ... cases are diagnosed annually. That said, not every ... powerful new technique, MRI Fusion Biopsy, to more ... treating only the affected areas and monitoring ...
Breaking Biology Technology:Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4
... of how business is conducted today, how important is ... ,Important enough that the expectations bar has been raised ... in recent years with the number of costly or ... in importance. But IT failures are just the tip ...
... the seventh in a series of articles on developing start-up ... article focused on business taxes. , , ... are ready to begin hiring workers. As discussed in the ... taxes, Social Security and Medicare taxes, ...
... . - Third Wave Technologies of Madison has ... lawsuit brought against it by Digene Corp . , ... for the Western District of Wisconsin in Madison, where ... includes counterclaims against Digene, alleging that it has abused its ...
Cached Biology Technology:Fusion 2007: CEOs say bar is raised for CIOs 2Fusion 2007: CEOs say bar is raised for CIOs 3Fusion 2007: CEOs say bar is raised for CIOs 4Early Stage 7, Part I: Just what is an employee? 2Early Stage 7, Part I: Just what is an employee? 3Early Stage 7, Part I: Just what is an employee? 4Early Stage 7, Part I: Just what is an employee? 5
(Date:9/2/2015)... , Sept. 2, 2015 Security ... concern for enterprises, banks, government organizations, telecommunications, hospitals, ... numeric keypads were previously being used to prevent ... of two-factor authentication, wherein individuals could gain access ... different components, such as hardware devices and numeric ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ) has ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Arabia Biomedical Sensors market is estimated at $0.23 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:8/24/2015)... 2015 The consulting company Frost & ... manufacturer DERMALOG and its customized solutions and products for ... of the Year Award". DERMALOG is particularly successful with a ... -Cross reference: Picture is available at AP Images ... On Thursday evening, in South Africa,s ...
Breaking Biology News(10 mins):Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3
... , , , , , ... , AUDIO: Plants capable of producing ... Click here for more information. , ... , , , , ...
... , ARLINGTON, VA (May 14, 2012) - ... groundbreaking research being unveiled at the American Association of ... takes place Monday, May 21 - Wednesday, May 23 ... topics to be discussed include diversity and complexity of ...
... San Diego has identified an approved arthritis drug that is ... could offer a low-dose, low cost treatment for the amoebic ... Based on these results, the team has received Orphan Drug ... Food and Drug Administration, and has applied for approval to ...
Cached Biology News:Supercharged safflower 2Supercharged safflower 3Supercharged safflower 4AAPS National Biotechnology Conference to highlight innovative vaccines 2Lab tests show arthritis drug effective against global parasite 2Lab tests show arthritis drug effective against global parasite 3Lab tests show arthritis drug effective against global parasite 4
Request Info...
... Transformation Kit is designed for rapid ... Advantages over commonly used transformation procedures ... methods include:- Cells can be made competent ... cell preparation and transformation solutions are ...
... BAC (100+kb), fosmid (40kb), and large plasmid ... any othe BAC vector. On command 20-50 ... easy recombinant DNA purification. Available with blue-white ... vectors for the highest insert stability. Kits ...
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
Biology Products: